Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
RKDA 
Arcadia Biosciences Inc (RKDA)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/17/2025: RKDA (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $12
1 Year Target Price $12
| 1 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -54.53% | Avg. Invested days 27 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/17/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 4.68M USD | Price to earnings Ratio - | 1Y Target Price 12 |
Price to earnings Ratio - | 1Y Target Price 12 | ||
Volume (30-day avg) 1 | Beta 0.57 | 52 Weeks Range 2.53 - 6.44 | Updated Date 09/17/2025 |
52 Weeks Range 2.53 - 6.44 | Updated Date 09/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -5.19 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -139.36% | Operating Margin (TTM) -103.16% |
Management Effectiveness
Return on Assets (TTM) -32.83% | Return on Equity (TTM) -87.94% |
Valuation
Trailing PE - | Forward PE 36.63 | Enterprise Value 250112 | Price to Sales(TTM) 0.87 |
Enterprise Value 250112 | Price to Sales(TTM) 0.87 | ||
Enterprise Value to Revenue 0.05 | Enterprise Value to EBITDA 0.62 | Shares Outstanding 1367040 | Shares Floating 1355830 |
Shares Outstanding 1367040 | Shares Floating 1355830 | ||
Percent Insiders 0.82 | Percent Institutions 4.33 |
Upturn AI SWOT
Arcadia Biosciences Inc
Company Overview
History and Background
Arcadia Biosciences Inc. was founded in 2002. It focuses on developing and commercializing agricultural products to improve the environment and human health. Initially focused on yield enhancement and abiotic stress tolerance, the company has shifted towards nutrition and consumer-facing products.
Core Business Areas
- Arcadia Wellness: Focuses on providing consumers with high-quality, plant-based wellness products, specifically CBD and Zola coconut water. Operates as a distinct consumer-facing brand.
- GoodWheat: Developing and commercializing wheat varieties with enhanced nutritional qualities, such as high fiber and reduced gluten.
- Sesame Seed: Developing seed and oil of sesame using the advanced genetic technologies in order to improve agricultural crops and provide solutions for a healthy lifestyle.
Leadership and Structure
The leadership team includes Stan Jacot as CEO. The company operates with functional departments and project-based teams to manage product development and commercialization efforts.
Top Products and Market Share
Key Offerings
- GoodWheat Flour: High-fiber wheat flour aimed at health-conscious consumers. Market share data is difficult to obtain specifically for GoodWheat flour but Arcadia has said they are working on increasing GoodWheat's brand market share with a focus on gluten intolerance, and other health and wellness areas. Competitors include traditional flour brands such as King Arthur Baking Company.
- Zola Coconut Water: A coconut water brand. No specific market share data available. Competitors include Vita Coco and Zico.
- Sesame Seeds: Sesame Seed product. Competitors includes Sesaco and Dipasa.
Market Dynamics
Industry Overview
The agricultural biotechnology industry is characterized by rapid innovation, increasing demand for sustainable food production, and growing consumer awareness of health and wellness. CBD market has been declining rapidly over the past 2 years due to oversupply. The coconut water market is competitive but growing.
Positioning
Arcadia Biosciences Inc positions itself as an innovator in agricultural technology, focusing on developing differentiated products with health and environmental benefits. Their competitive advantage lies in their proprietary genetic technologies and focus on niche markets.
Total Addressable Market (TAM)
The TAM for enhanced wheat flour is estimated to be several billion dollars globally. Arcadia is focused on capturing a growing share of the market for better-for-you food ingredients and consumer packaged goods.
Upturn SWOT Analysis
Strengths
- Proprietary genetic technologies
- Focus on health and wellness trends
- Consumer product brands
- GoodWheat is high in fiber
Weaknesses
- Limited financial resources
- Reliance on partnerships for commercialization
- Small market share in competitive markets
- CBD market decline and increased competition.
Opportunities
- Expanding distribution channels
- Developing new product applications for GoodWheat
- Entering new geographic markets
- Increased demand for sustainable and healthy food options
Threats
- Competition from larger agricultural companies
- Regulatory hurdles for genetically modified crops
- Fluctuations in commodity prices
- Changing consumer preferences
Competitors and Market Share
Key Competitors
- BGNE
- KRYS
Competitive Landscape
Arcadia Biosciences Inc. faces stiff competition from larger, more established agricultural companies. Its competitive advantage lies in its focus on niche markets and proprietary technologies. However, its limited financial resources and smaller market share present challenges.
Growth Trajectory and Initiatives
Historical Growth: Historical growth data is not available without access to a financial database. Therefore, this section cannot be completed.
Future Projections: Future projections are not available without access to a financial database. Therefore, this section cannot be completed.
Recent Initiatives: Recent initiatives include focusing on the GoodWheat portfolio, partnership developments, and brand expansion.
Summary
Arcadia Biosciences Inc. is a smaller player in the agricultural biotechnology industry. GoodWheat and Zola have some growth potential. The company must carefully manage its resources and partnerships to compete effectively. The declining CBD market puts some pressure on profitability.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company website
- SEC filings
- Industry reports
Disclaimers:
The information provided is for informational purposes only and should not be considered investment advice. Market share estimates are based on available data and may not be precise. Financial data is based on historical information and is subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Arcadia Biosciences Inc
Exchange NASDAQ | Headquaters Dallas, TX, United States | ||
IPO Launch date 2015-05-15 | CEO, President & Director Mr. Thomas J. Schaefer C.F.A. | ||
Sector Consumer Defensive | Industry Packaged Foods | Full time employees 9 | Website https://www.arcadiabio.com |
Full time employees 9 | Website https://www.arcadiabio.com | ||
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.